Literature DB >> 6957279

Platelet phenol sulfotransferase activity: correlation with sulfate conjugation of acetaminophen.

C Reiter, R Weinshilboum.   

Abstract

Human platelets contain two independently regulated forms of the drug conjugating enzyme, phenol sulfotransferase (PST). One form of platelet PST activity is relatively thermolabile (TL) and the other is relatively thermostable (TS). Acetaminophen is a substrate for both the TS and TL forms of PST. Our aim was to determine whether individual variations in platelet PST activity might reflect variations in teh sulfate conjugation of oral acetaminophen. Platelet PST activity was measured in blood samples from 29 randomly selected subjects. There was no significant correlation between the independently regulated activities of the TS and TL forms of PST in the platelets of these subjects (r = 0.16, P less than 0.4). Each of the 29 subjects ingested 10 mg/kg acetaminophen and 24-hr urinary excretions of acetaminophen, acetaminophen glucuronide, and acetaminophen sulfate were measured. Average 24-hr urinary excretions of acetaminophen, acetaminophen glucuronide, and acetaminophen sulfate were 2.3%, 46.9%, and 35.0% of the total dose of drug. There were significant correlations between the activities of both the TS and TL forms of platelet PST and the excretion of acetaminophen sulfate expressed as a percentage of the dose of the drug (r = 0.62, P less than 0.001; r = 0.456, P less than 0.02). The correlation coefficient between the TS activity and the excretion of acetaminophen sulfate was significant when the excretion of sulfate conjugate was expressed as a percentage of the sum of acetaminophen plus conjugated metabolites excreted (r = 0.565, P less than 0.002). Our data demonstrate that relative levels of platelet PST activity reflect individual variations in the urinary excretion of the sulfate conjugate of acetaminophen.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6957279     DOI: 10.1038/clpt.1982.211

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  8 in total

1.  Sulphate conjugation of p-hydroxytriamterene by platelet phenol sulphotransferase: assay conditions and correlation with metabolism in man.

Authors:  C Reiter; P G Werness; J Van Loon; L H Smith; R M Weinshilboum
Journal:  Br J Clin Pharmacol       Date:  1983-02       Impact factor: 4.335

2.  Pharmacokinetics of paracetamol and its metabolites in women at delivery and post-partum.

Authors:  Aida Kulo; Mariska Y Peeters; Karel Allegaert; Anne Smits; Jan de Hoon; Rene Verbesselt; Liesbeth Lewi; Marc van de Velde; Catherijne A J Knibbe
Journal:  Br J Clin Pharmacol       Date:  2013-03       Impact factor: 4.335

3.  The human phenolsulphotransferase polymorphism is determined by the level of expression of the enzyme protein.

Authors:  A L Jones; R C Roberts; M W Coughtrie
Journal:  Biochem J       Date:  1993-12-01       Impact factor: 3.857

4.  Thermolabile and thermostable human platelet phenol sulfotransferase. Substrate specificity and physical separation.

Authors:  C Reiter; G Mwaluko; J Dunnette; J Van Loon; R Weinshilboum
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-09       Impact factor: 3.000

5.  Human platelet phenol sulfotransferase: familial variation in thermal stability of the TS form.

Authors:  J Van Loon; R M Weinshilboum
Journal:  Biochem Genet       Date:  1984-12       Impact factor: 1.890

6.  Sulfur metabolism in ulcerative colitis: investigation of detoxification enzymes in peripheral blood.

Authors:  M C Pitcher; E R Beatty; R M Harris; R H Waring; J H Cummings
Journal:  Dig Dis Sci       Date:  1998-09       Impact factor: 3.199

7.  Interindividual variability of phenol- and catechol-sulphotransferases in platelets from adults and newborns.

Authors:  G M Pacifici; G Marchi
Journal:  Br J Clin Pharmacol       Date:  1993-12       Impact factor: 4.335

8.  A simple method to measure sulfonation in man using paracetamol as probe drug.

Authors:  Emília C Monteiro; Sofia A Pereira; Natália Marto; Judit Morello; Alexandra M M Antunes; Sofia Azeredo
Journal:  Sci Rep       Date:  2021-04-27       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.